265 related articles for article (PubMed ID: 11470749)
1. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study.
Zheng Y; Shen H; Sturgis EM; Wang LE; Eicher SA; Strom SS; Frazier ML; Spitz MR; Wei Q
Carcinogenesis; 2001 Aug; 22(8):1195-9. PubMed ID: 11470749
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.
Holley SL; Parkes G; Matthias C; Bockmühl U; Jahnke V; Leder K; Strange RC; Fryer AA; Hoban PR
Am J Pathol; 2001 Nov; 159(5):1917-24. PubMed ID: 11696452
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
[TBL] [Abstract][Full Text] [Related]
5. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Amos CI; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Carcinogenesis; 2004 Oct; 25(10):1911-6. PubMed ID: 15180941
[TBL] [Abstract][Full Text] [Related]
6. Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent.
Zhong S; Nukui T; Buch S; Diergaarde B; Weissfeld LA; Grandis J; Romkes M; Weissfeld JL
Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2429-37. PubMed ID: 21890746
[TBL] [Abstract][Full Text] [Related]
7. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck.
Sturgis EM; Dahlstrom KR; Spitz MR; Wei Q
Arch Otolaryngol Head Neck Surg; 2002 Sep; 128(9):1084-8. PubMed ID: 12220217
[TBL] [Abstract][Full Text] [Related]
8. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis.
Sturgis EM; Zheng R; Li L; Castillo EJ; Eicher SA; Chen M; Strom SS; Spitz MR; Wei Q
Carcinogenesis; 2000 Dec; 21(12):2219-23. PubMed ID: 11133811
[TBL] [Abstract][Full Text] [Related]
9. Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract.
Buch S; Zhu B; Davis AG; Odom D; Siegfried JM; Grandis JR; Romkes M
Mol Carcinog; 2005 Apr; 42(4):222-8. PubMed ID: 15754315
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck.
Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q
Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in non-alcoholics.
Nishimoto IN; Pinheiro NA; Rogatto SR; Carvalho AL; Simpson AJ; Caballero OL; Kowalski LP
Oral Oncol; 2004 Jul; 40(6):604-10. PubMed ID: 15063389
[TBL] [Abstract][Full Text] [Related]
12. Significance of cyclin D1 polymorphisms in patients with head and neck cancer.
Sabir M; Baig RM; Mahjabeen I; Kayani MA
Int J Biol Markers; 2013 Apr; 28(1):49-55. PubMed ID: 23125009
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population.
Qiuling S; Yuxin Z; Suhua Z; Cheng X; Shuguang L; Fengsheng H
Carcinogenesis; 2003 Sep; 24(9):1499-503. PubMed ID: 12807740
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
Wang L; Habuchi T; Takahashi T; Mitsumori K; Kamoto T; Kakehi Y; Kakinuma H; Sato K; Nakamura A; Ogawa O; Kato T
Carcinogenesis; 2002 Feb; 23(2):257-64. PubMed ID: 11872630
[TBL] [Abstract][Full Text] [Related]
15. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3996-4002. PubMed ID: 15217930
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
Zhang Z; Wang LE; Sturgis EM; El-Naggar AK; Hong WK; Amos CI; Spitz MR; Wei Q
Clin Cancer Res; 2006 Sep; 12(18):5596-602. PubMed ID: 17000697
[TBL] [Abstract][Full Text] [Related]
18. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study.
Shen H; Zheng Y; Sturgis EM; Spitz MR; Wei Q
Cancer Lett; 2002 Sep; 183(2):123-30. PubMed ID: 12065086
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis.
Zhang Z; Shi Q; Liu Z; Sturgis EM; Spitz MR; Wei Q
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1188-93. PubMed ID: 15894670
[TBL] [Abstract][Full Text] [Related]
20. CCND1 G870A polymorphism and risk for head and neck cancer: a meta-analysis.
Tang C; Wang Z; Yu J; Wu Y; Zhu Z; Chen N
Med Oncol; 2011 Dec; 28(4):1319-24. PubMed ID: 20443083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]